Archived articles

Covid-19 vaccine

Q+A
Why and when to get a bivalent booster
Published Oct 6, 2022
The newly available COVID-19 boosters offer the best protection against current strains. But who needs it and when should they get it?
COVID-19 Vaccines
What you need to know about bivalent boosters for COVID-19
Published Sept 1, 2022
New booster shots designed to target the omicron variant and its subvariants, and the original strain of SARS-CoV-2, could become available in the U.S. in the coming weeks
Vaccination
U.S. rolls out COVID-19 vaccines for youngest children
Published June 23, 2022
The CDC and FDA approved vaccines by Moderna and Pfizer/BioNTech in children older than 6 months; vaccinations began this week
Vaccination
FDA authorizes COVID-19 vaccines for children under 5 years old. What's next?
Published June 16, 2022
Vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks
COVID-19
What you need to know about the Novavax vaccine
Published June 16, 2022
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19. Vaccine expert William Moss discusses its strengths and weaknesses ahead of its potential emergency use authorization.
Coronavirus
The pandemic has reached a plateau, but for how long?
Published June 8, 2022
Johns Hopkins health security expert Tom Inglesby provides an update on the state of the pandemic and how vaccination, funding, and variants may affect its future
Immunity
Antibodies point researchers toward broad coronavirus vaccines
Published June 8, 2022
Certain antibodies isolated from people who had recovered from COVID-19 and were vaccinated have the ability to neutralize variety of coronaviruses
Pandemic data
One million lives lost to COVID-19
Published May 17, 2022
Experts say the tragic milestone, now recorded by the Coronavirus Resource Center tracker, likely occurred months ago and that higher vaccination rates could have prevented many fatalities
Virtual assistant
Chatbots battle COVID-19 vaccine hesitancy
Published March 24, 2022
Researchers at Johns Hopkins had already been developing chatbots to combat vaccine misinformation when the coronavirus pandemic arrived, giving their work greater urgency
COVID-19
Study: Children's antibody responses to COVID-19 are stronger than adults'
Published March 22, 2022
Findings differ from earlier reports of low antibody responses in children exposed to COVID-19 virus and suggest that even the youngest children may respond to vaccines if correct dose is determined